Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy-Reference-Cited by-同舟云学术

Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy

Published:2023-02 Issue: Volume:158 Page:114141
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Ma Oscar Ka-Fai,Ronsisvalle Simone,Basile Livia,Xiang Ariya Weiman,Tomasella Cristina,Sipala Federica,Pappalardo Matteo,Chan Koon-Ho,Milardi Danilo,Ng Roy Chun-Laam,Guccione Salvatore

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain;Feldman;Neuron,2017

2. Motor end plate innervation loss in diabetes and the role of insulin;Francis;J. Neuropathol. Exp. Neurol.,2011

3. Involvement of oxidative stress and impaired lysosomal degradation in amiodarone-induced schwannopathy;Niimi;Eur. J. Neurosci.,2016

4. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy;Schmeichel;Diabetes,2003

5. Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss;Hall;Sci. Rep.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2023;Peptides;2024-09

2. Adiponectin as a therapeutic target for diabetic foot ulcer;World Journal of Diabetes;2023-06-15

3. Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications;Diabetes, Metabolic Syndrome and Obesity;2023-01